@xiaodidi
On May 16th, Kaipu Biotechnology announced that its wholly-owned subsidiary Kaipu Pharmaceutical Technology Co., Ltd.'s genetic testing kit for hereditary deafness (PCR+guided hybridization method) has been awarded in vitro diagnostic reagents by the National Medical Products Administration